Changes in verbal learning of patients with schizophrenia: Results from a randomized, double-blind, placebo-controlled trial of amantadine adjunctive to antipsychotics

被引：3
作者：
Czepielewski, Leticia S. [1 ]
Sodre, Leonardo [1 ]
Souza, Ana Claudia L. [1 ]
Buecker, Joana [1 ]
Burke, Kelen P. [1 ]
Cereser, Keila M. [1 ]
Gama, Clarissa S. [1 ]
机构：
[1] Univ Fed Rio Grande do Sul, Post Grad Program Med, Dept Psychiat, Lab Mol Psychiat,Hosp Clin Porto Alegre, BR-90035903 Porto Alegre, RS, Brazil
来源：
SCHIZOPHRENIA RESEARCH | 2015年 / 168卷 / 1-2期
关键词：
METAANALYSIS; RELIABILITY; IMPAIRMENT;
D O I：
10.1016/j.schres.2015.06.001
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：571 / 572
页数：2
相关论文
共 10 条
  • [1] Hopkins Verbal Learning Test Revised: Normative data and analysis of inter-form and test-retest reliability
    Benedict, RHB
    Schretlen, D
    Groninger, L
    Brandt, J
    [J]. CLINICAL NEUROPSYCHOLOGIST, 1998, 12 (01): : 43 - 55
  • [2] May Non-antipsychotic Drugs Improve Cognition of Schizophrenia Patients?
    Buoli, M.
    Altamura, A. C.
    [J]. PHARMACOPSYCHIATRY, 2015, 48 (02) : 41 - 50
  • [3] Cohen S.M., 2015, SCHIZOPHR RES
  • [4] Functional mechanisms of episodic memory impairment in schizophrenia
    Danion, Jean-Marie
    Huron, Caroline
    Vidailhet, Pierre
    Berna, Fabrice
    [J]. CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2007, 52 (11): : 693 - 701
  • [5] Improvement of Negative and Positive Symptoms in Treatment-Refractory Schizophrenia: A Double-Blind, Randomized, Placebo-Controlled Trial With Memantine as Add-On Therapy to Clozapine
    de Lucena, David
    Fernandes, Brisa Simoes
    Berk, Michael
    Dodd, Seetal
    Medeiros, Dalton W.
    Pedrini, Mariana
    Kunz, Mauricio
    Gomes, Fabiano Alves
    Giglio, Larriany F.
    Lobato, Maria Ines
    Belmonte-de-Abreu, Paulo Silva
    Gama, Clarissa Severino
    [J]. JOURNAL OF CLINICAL PSYCHIATRY, 2009, 70 (10) : 1416 - 1423
  • [6] Short-Term Treatment of Catatonia With Amantadine in Schizophrenia and Schizoaffective Disorder
    de Lucena, David Freitas
    Pinto, Joel Porfirio
    Hallak, Jaime E.
    Crippa, Jose Alexandre
    Gama, Clarissa Severino
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2012, 32 (04) : 569 - 572
  • [7] NMDA receptor antagonists interventions in schizophrenia: Meta-analysis of randomized, placebo-controlled trials
    Kishi, Taro
    Iwata, Nakao
    [J]. JOURNAL OF PSYCHIATRIC RESEARCH, 2013, 47 (09) : 1143 - 1149
  • [8] The MATRICS consensus cognitive battery, part 1: Test selection, reliability, and validity
    Nuechterlein, Keith H.
    Green, Michael F.
    Kern, Robert S.
    Baade, Lyle E.
    Barch, Deanna M.
    Cohen, Jonathan D.
    Essock, Susan
    Fenton, Wayne S.
    Frese, Frederick J., III
    Gold, James M.
    Goldberg, Terry
    Heaton, Robert K.
    Keefe, Richard S. E.
    Kraemer, Helena
    Mesholam-Gately, Raquelle
    Seidman, Larry J.
    Stover, Ellen
    Weinberger, Daniel R.
    Young, Alexander S.
    Zalcman, Steven
    Marder, Stephen R.
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2008, 165 (02) : 203 - 213
  • [9] The global cognitive impairment in schizophrenia: Consistent over decades and around the world
    Schaefer, Jonathan
    Giangrande, Evan
    Weinberger, Daniel R.
    Dickinson, Dwight
    [J]. SCHIZOPHRENIA RESEARCH, 2013, 150 (01) : 42 - 50
  • [10] A Meta-Analysis of Cognitive Remediation for Schizophrenia: Methodology and Effect Sizes
    Wykes, Til
    Huddy, Vyv
    Cellard, Caroline
    McGurk, Susan R.
    Czobor, Pal
    [J]. AMERICAN JOURNAL OF PSYCHIATRY, 2011, 168 (05) : 472 - 485
1